When Marcos C. Perez was diagnosed with chronic myeloid leukemia, an uncommon cancer of the blood-producing cells of the bone marrow, he began treatment at Sylvester Comprehensive Cancer Center. After three rounds of chemotherapy, Perez received stem cell transplants to rebuild the white blood cells in his immune system. "I am very positive about my outcome, because so many patients come out of Sylvester as winners."
Acclaimed Miami artist Peter Tunney donated his time and talent to help Sylvester Comprehensive Cancer Center launch a “Game Changer” outreach vehicle that will bring cancer screenings and health information to underserved South Florida communities. Using images from Sylvester’s history and mission, Tunney created an original piece of art to “wrap” the mobile van, which was unveiled outside Tunney’s Wynwood studio.
Monday, March 12, begins UHealth’s observance of Patient Safety Awareness Week — an annual national campaign to increase awareness about patient safety among health care professionals and the public. This year’s theme is “Every Day is Patient Safety Day!” — an affirmation of our dedication to creating the safest possible environment for our patients and for each other.
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, collaborating with outside investigators, has discovered a new pathway of inflammation-driven cancer development. Their findings, “Initiation of Inflammatory Tumorigenesis by CTLA4 Insufficiency Due to Type 2 Cytokines,” were published online on January 26 by the Journal of Experimental Medicine.
Barbara A. Vance, Ph.D., CRA, will join Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine on March 17 as assistant vice president and associate director for administration. Vance will be a senior member of Sylvester’s leadership team, responsible for efficient operations and financial performance, including submission of the National Cancer Institute (NCI) Cancer Center Support Grant.
Dr. Jaime Merchan is thrilled that Sylvester Comprehensive Cancer Center has reached the milestone number of 100 patients enrolled in a single year in its Phase 1 clinical trials program. The program, which tests new drugs and other novel treatment strategies for advanced solid tumors and hematological malignances, offers these patients something they couldn’t find elsewhere: hope.
Patients treated with chemotherapy for some of the most common types of cancer at Dedicated Cancer Centers have higher survival rates compared to patients treated at other types of hospitals, according to new analysis conducted by Milliman for the Alliance of Dedicated Cancer Centers. Sylvester Comprehensive Cancer Center is one of only 11 members of the Alliance of Dedicated Cancer Centers.
Sylvester Comprehensive Cancer Center has once again been recognized as a Cancer Center of Excellence by the State of Florida — one of just four cancer centers in the state, and the only one in South Florida, to have earned this honor. The designation recognizes providers that exceed service standards and excel in providing quality, comprehensive and patient-centered, coordinated care for cancer patients in Florida.
Florida Blue has renewed its Blue Distinction Center for Transplants designation for the adult bone marrow transplant program at Sylvester Comprehensive Cancer Center. The renewed designation is recognition that the program at Sylvester, part of UHealth – the University of Miami Health System, continues to meet the insurer’s national standards for high quality care and outcomes.
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine welcomed the State of Florida’s Chief Financial Officer, Jimmy Patronis, on February 5, giving him a tour of its cancer-fighting technologies. Patronis also met with representatives from more than a dozen of South Florida’s fire departments whose members are collaborating with Sylvester’s Firefighters Cancer Initiative.